6.
Tsai M, Mallampalli R
. E-Cigarette or Vaping Product Use-associated Lung Injury: Opportunities and Challenges. Am J Respir Cell Mol Biol. 2020; 62(3):397-398.
DOI: 10.1165/rcmb.2019-0422LE.
View
7.
Xie W, Kathuria H, Galiatsatos P, Blaha M, Hamburg N, Robertson R
. Association of Electronic Cigarette Use With Incident Respiratory Conditions Among US Adults From 2013 to 2018. JAMA Netw Open. 2020; 3(11):e2020816.
PMC: 7662143.
DOI: 10.1001/jamanetworkopen.2020.20816.
View
8.
Blagev D, Harris D, Dunn A, Guidry D, Grissom C, Lanspa M
. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study. Lancet. 2019; 394(10214):2073-2083.
DOI: 10.1016/S0140-6736(19)32679-0.
View
9.
Layden J, Ghinai I, Pray I, Kimball A, Layer M, Tenforde M
. Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Final Report. N Engl J Med. 2019; 382(10):903-916.
DOI: 10.1056/NEJMoa1911614.
View
10.
Cullen K, Gentzke A, Sawdey M, Chang J, Anic G, Wang T
. e-Cigarette Use Among Youth in the United States, 2019. JAMA. 2019; 322(21):2095-2103.
PMC: 6865299.
DOI: 10.1001/jama.2019.18387.
View
11.
Hajek P, Phillips-Waller A, Przulj D, Pesola F, Smith K, Bisal N
. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med. 2019; 380(7):629-637.
DOI: 10.1056/NEJMoa1808779.
View
12.
Callahan S, Harris D, Collingridge D, Guidry D, Dean N, Lanspa M
. Diagnosing EVALI in the Time of COVID-19. Chest. 2020; 158(5):2034-2037.
PMC: 7319621.
DOI: 10.1016/j.chest.2020.06.029.
View
13.
Kalininskiy A, Bach C, Nacca N, Ginsberg G, Marraffa J, Navarette K
. E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. Lancet Respir Med. 2019; 7(12):1017-1026.
PMC: 11077418.
DOI: 10.1016/S2213-2600(19)30415-1.
View
14.
Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J
. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013; 382(9905):1629-37.
DOI: 10.1016/S0140-6736(13)61842-5.
View
15.
Serpa G, Renton N, Lee N, Crane M, Jamieson A
. Electronic Nicotine Delivery System Aerosol-induced Cell Death and Dysfunction in Macrophages and Lung Epithelial Cells. Am J Respir Cell Mol Biol. 2020; 63(3):306-316.
PMC: 7462344.
DOI: 10.1165/rcmb.2019-0200OC.
View
16.
Szafran B, Pinkston R, Perveen Z, Ross M, Morgan T, Paulsen D
. Electronic-Cigarette Vehicles and Flavoring Affect Lung Function and Immune Responses in a Murine Model. Int J Mol Sci. 2020; 21(17).
PMC: 7504509.
DOI: 10.3390/ijms21176022.
View
17.
Sindelar J
. Regulating Vaping - Policies, Possibilities, and Perils. N Engl J Med. 2020; 382(20):e54.
DOI: 10.1056/NEJMp1917065.
View
18.
Chaumont M, van de Borne P, Bernard A, Van Muylem A, Deprez G, Ullmo J
. Fourth generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. Am J Physiol Lung Cell Mol Physiol. 2019; 316(5):L705-L719.
PMC: 6589591.
DOI: 10.1152/ajplung.00492.2018.
View
19.
Wills T, Soneji S, Choi K, Jaspers I, Tam E
. E-cigarette use and respiratory disorders: an integrative review of converging evidence from epidemiological and laboratory studies. Eur Respir J. 2020; 57(1).
PMC: 7817920.
DOI: 10.1183/13993003.01815-2019.
View
20.
Eissenberg T, Bhatnagar A, Chapman S, Jordt S, Shihadeh A, Soule E
. Invalidity of an Oft-Cited Estimate of the Relative Harms of Electronic Cigarettes. Am J Public Health. 2020; 110(2):161-162.
PMC: 6951374.
DOI: 10.2105/AJPH.2019.305424.
View